Friday, December 27, 2013

The Motley Fool: CareFusion Corporation: A Mid-Cap Med-Tech Leader

A lot of attention has historically been paid to CareFusion Corporation (NYSE: CFN  ) in the context of its place in the infusion pump oligopoly with Baxter (NYSE: BAX  ) and Hospira (NYSE: HSP  ) . There is a lot more to this story, though, as the company is a leader in medication dispensing, pre-op skin prep, and respiratory care. The acquisition of Vital Signs from General Electric will add scale in respiratory care and anesthesia, but leaves the company with enough dry powder to continue making additive deals. CareFusion is not a slam-dunk bargain, and there aren't many of those left in med-tech, but it is a name worth consideration today or at least a spot on investor watchlists.

Please continue here:
CareFusion Corporation: A Mid-Cap Med-Tech Leader

No comments: